Medical oncologist, clinician researcher, Peter McCallum Cancer Centre.
Cemiplimab Shows Promising Results in Adjuvant Treatment for CSCC: Danny Rischin, MD
June 2nd 2025Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant treatment approach for patients with locally advanced cutaneous squamous cell carcinoma (CSCC).